Logo image of GP

GREENPOWER MOTOR CO INC (GP) Stock Fundamental Analysis

NASDAQ:GP - Nasdaq - CA39540E3023 - Common Stock - Currency: USD

0.4499  0 (-0.02%)

After market: 0.4351 -0.01 (-3.29%)

Fundamental Rating

1

Overall GP gets a fundamental rating of 1 out of 10. We evaluated GP against 128 industry peers in the Machinery industry. Both the profitability and financial health of GP have multiple concerns. While showing a medium growth rate, GP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GP had negative earnings in the past year.
GP had a negative operating cash flow in the past year.
GP had negative earnings in each of the past 5 years.
GP had a negative operating cash flow in each of the past 5 years.
GP Yearly Net Income VS EBIT VS OCF VS FCFGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

GP has a Return On Assets of -57.43%. This is amonst the worse of the industry: GP underperforms 89.84% of its industry peers.
GP has a worse Return On Equity (-1003.70%) than 90.63% of its industry peers.
Industry RankSector Rank
ROA -57.43%
ROE -1003.7%
ROIC N/A
ROA(3y)-31.51%
ROA(5y)-30.65%
ROE(3y)-85.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GP Yearly ROA, ROE, ROICGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

The Gross Margin of GP (8.32%) is worse than 89.06% of its industry peers.
GP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for GP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.3%
GM growth 5Y-14.89%
GP Yearly Profit, Operating, Gross MarginsGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

0

2. Health

2.1 Basic Checks

GP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GP has been increased compared to 1 year ago.
Compared to 5 years ago, GP has more shares outstanding
GP has a worse debt/assets ratio than last year.
GP Yearly Shares OutstandingGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GP Yearly Total Debt VS Total AssetsGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

GP has an Altman-Z score of -3.44. This is a bad value and indicates that GP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GP (-3.44) is worse than 87.50% of its industry peers.
GP has a Debt/Equity ratio of 5.73. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of GP (5.73) is worse than 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF N/A
Altman-Z -3.44
ROIC/WACCN/A
WACC8.49%
GP Yearly LT Debt VS Equity VS FCFGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 1.68 indicates that GP should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.68, GP is doing worse than 65.63% of the companies in the same industry.
A Quick Ratio of 0.18 indicates that GP may have some problems paying its short term obligations.
With a Quick ratio value of 0.18, GP is not doing good in the industry: 94.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.18
GP Yearly Current Assets VS Current LiabilitesGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for GP have decreased strongly by -36.07% in the last year.
The Revenue for GP has decreased by -58.29% in the past year. This is quite bad
Measured over the past years, GP shows a very strong growth in Revenue. The Revenue has been growing by 45.21% on average per year.
EPS 1Y (TTM)-36.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-58.29%
Revenue growth 3Y43.51%
Revenue growth 5Y45.21%
Sales Q2Q%-11.51%

3.2 Future

GP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.60% yearly.
Based on estimates for the next years, GP will show a quite strong growth in Revenue. The Revenue will grow by 17.68% on average per year.
EPS Next Y-1.57%
EPS Next 2Y14.91%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue Next Year-44.95%
Revenue Next 2Y3.41%
Revenue Next 3Y17.68%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
GP Yearly Revenue VS EstimatesGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
GP Yearly EPS VS EstimatesGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GP Price Earnings VS Forward Price EarningsGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GP Per share dataGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

GP's earnings are expected to grow with 16.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.91%
EPS Next 3Y16.6%

More info and screens

0

5. Dividend

5.1 Amount

GP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENPOWER MOTOR CO INC

NASDAQ:GP (5/23/2025, 8:19:59 PM)

After market: 0.4351 -0.01 (-3.29%)

0.4499

0 (-0.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)06-30 2025-06-30/bmo
Inst Owners2.02%
Inst Owner Change95.98%
Ins Owners22.37%
Ins Owner ChangeN/A
Market Cap13.27M
Analysts84.44
Price Target1.27 (182.28%)
Short Float %2.31%
Short Ratio7.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.44%
Min EPS beat(2)-0.03%
Max EPS beat(2)2.91%
EPS beat(4)2
Avg EPS beat(4)-11.54%
Min EPS beat(4)-54.2%
Max EPS beat(4)5.17%
EPS beat(8)2
Avg EPS beat(8)-17.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)8.78%
Min Revenue beat(2)-6.47%
Max Revenue beat(2)24.04%
Revenue beat(4)1
Avg Revenue beat(4)-12.85%
Min Revenue beat(4)-40.62%
Max Revenue beat(4)24.04%
Revenue beat(8)2
Avg Revenue beat(8)-15.72%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.87%
PT rev (3m)1.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 6.21
P/tB 6.21
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0.7
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.43%
ROE -1003.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.32%
FCFM N/A
ROA(3y)-31.51%
ROA(5y)-30.65%
ROE(3y)-85.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.3%
GM growth 5Y-14.89%
F-Score1
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.42%
Cap/Sales 0.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 0.18
Altman-Z -3.44
F-Score1
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)43.22%
Cap/Depr(5y)47.66%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-1.57%
EPS Next 2Y14.91%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-58.29%
Revenue growth 3Y43.51%
Revenue growth 5Y45.21%
Sales Q2Q%-11.51%
Revenue Next Year-44.95%
Revenue Next 2Y3.41%
Revenue Next 3Y17.68%
Revenue Next 5YN/A
EBIT growth 1Y-40.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.06%
EBIT Next 3Y18.64%
EBIT Next 5YN/A
FCF growth 1Y1.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.63%
OCF growth 3YN/A
OCF growth 5YN/A